Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126616551 | 12661655 | 1 | I | 201606 | 20160815 | 20160817 | 20160817 | PER | US-PFIZER INC-2016388786 | PFIZER | 79.00 | YR | F | Y | 73.94000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126616551 | 12661655 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | M76000 | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126616551 | 12661655 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 2X/DAY | M76000 | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | BID | |||||
| 126616551 | 12661655 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 80 MG, DAILY (80MG ONE TABLET BY MOUTH EVERY DAY) | 0 | 80 | MG | TABLET | |||||||
| 126616551 | 12661655 | 4 | C | LOSARTAN. | LOSARTAN | 1 | 25 MG, DAILY (25MG ONE DAY) | 0 | 25 | MG | |||||||||
| 126616551 | 12661655 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 126616551 | 12661655 | 6 | C | AROMASIN | EXEMESTANE | 1 | 25 MG, 1X/DAY (25 MG TABLET ONCE A DAY WITH MEAL) | 0 | 25 | MG | TABLET | QD | |||||||
| 126616551 | 12661655 | 7 | C | CALCIUM PLUS VITAMIN D | CALCIUMVITAMIN D | 1 | 1200 MG, 1X/DAY | 0 | 1200 | MG | QD | ||||||||
| 126616551 | 12661655 | 8 | C | VICKS NYQUIL | ACETAMINOPHENDEXTROMETHORPHAN HYDROBROMIDEDOXYLAMINE SUCCINATE | 1 | 1 DF, DAILY (ONE CAPSULE AT NIGHT) | 0 | 1 | DF | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126616551 | 12661655 | 6 | Breast cancer |
| 126616551 | 12661655 | 7 | Osteoporosis |
| 126616551 | 12661655 | 8 | Sleep disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126616551 | 12661655 | Anxiety | |
| 126616551 | 12661655 | Drug prescribing error | |
| 126616551 | 12661655 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126616551 | 12661655 | 2 | 201606 | 0 | ||
| 126616551 | 12661655 | 6 | 2013 | 0 | ||
| 126616551 | 12661655 | 7 | 2015 | 0 |